Iovance Biotherapeutics Inc Financial Flexibility Index
Iovance Biotherapeutics Inc financial flexibility index. Iovance Biotherapeutics Inc (IOVA) has a Financial Flexibility Index of -0.33x as of September 2025. Free cash flow of $-67.86 Million (operating CF $-78.70 Million minus capex $10.84 Million) represents 0% of total liabilities ($202.66 Million). See Iovance Biotherapeutics Inc (IOVA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Iovance Biotherapeutics Inc (2008–2024)
Financial flexibility index of Iovance Biotherapeutics Inc from 2008 to 2024. Historical Financial Flexibility Index trend for Iovance Biotherapeutics Inc across 17 annual periods. Check cash flow quality index of Iovance Biotherapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Iovance Biotherapeutics Inc Financial Flexibility Index by Year (2008–2024)
Iovance Biotherapeutics Inc financial flexibility index by year from 2008 to 2024. Year-by-year free cash flow to debt coverage for Iovance Biotherapeutics Inc. For the full cash flow conversion analysis, see Iovance Biotherapeutics Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.71x | $-341.91 Million | $-352.98 Million | $200.02 Million | ▲ +1.5% |
| 2023 | -1.73x | $-339.53 Million | $-361.82 Million | $195.74 Million | ▼ -4.7% |
| 2022 | -1.66x | $-272.33 Million | $-292.76 Million | $164.34 Million | ▼ -35.5% |
| 2021 | -1.22x | $-190.37 Million | $-227.94 Million | $155.67 Million | ▲ +13.5% |
| 2020 | -1.41x | $-158.34 Million | $-205.13 Million | $111.96 Million | ▲ +57.5% |
| 2019 | -3.33x | $-151.97 Million | $-158.89 Million | $45.68 Million | ▲ +51.4% |
| 2018 | -6.84x | $-100.05 Million | $-101.25 Million | $14.63 Million | ▲ +12.9% |
| 2017 | -7.85x | $-77.68 Million | $-78.71 Million | $9.89 Million | ▼ -25.3% |
| 2016 | -6.27x | $-31.15 Million | $-32.67 Million | $4.97 Million | ▲ +40.7% |
| 2015 | -10.58x | $-17.24 Million | $-18.38 Million | $1.63 Million | ▼ -149.6% |
| 2014 | -4.24x | $-7.04 Million | $-8.63 Million | $1.66 Million | ▼ -163.5% |
| 2013 | -1.61x | $-3.65 Million | $-3.66 Million | $2.27 Million | ▼ -714.0% |
| 2012 | -0.20x | $-2.24 Million | $-2.24 Million | $11.35 Million | ▲ +57.2% |
| 2011 | -0.46x | $-6.16 Million | $-6.19 Million | $13.35 Million | ▲ +38.9% |
| 2010 | -0.75x | $-620.80K | $-620.80K | $822.87K | ▼ -20.7% |
| 2009 | -0.62x | $-14.45K | $-14.45K | $23.12K | ▲ +96.4% |
| 2008 | -17.22x | $-57.30K | $-57.30K | $3.33K | — |